These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 24120632

  • 21. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.
    Varlotto JM, Recht A, Nikolov M, Flickinger JC, Decamp MM.
    Cancer; 2009 Feb 15; 115(4):851-8. PubMed ID: 19140203
    [Abstract] [Full Text] [Related]

  • 22. Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker.
    Nosotti M, Falleni M, Palleschi A, Pellegrini C, Alessi F, Bosari S, Santambrogio L.
    Chest; 2005 Sep 15; 128(3):1539-44. PubMed ID: 16162755
    [Abstract] [Full Text] [Related]

  • 23. [Feasibility and its clinical significance of detection of LUNX mRNA expression in diagnosis of micrometastasis for non-small cell lung cancer].
    Zhang P, Liu Y, Chen J, Song S, Shang Z.
    Zhongguo Fei Ai Za Zhi; 2006 Dec 20; 9(6):506-10. PubMed ID: 21182811
    [Abstract] [Full Text] [Related]

  • 24. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH, Cheng YW, Chang JT, Wu TC, Chen CY, Lee H.
    Cancer; 2007 Jul 01; 110(1):215-23. PubMed ID: 17508409
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.
    Timotheadou E, Skarlos DV, Samantas E, Papadopoulos S, Murray S, Skrickova J, Christodoulou C, Papakostantinou C, Pectasides D, Papakostas P, Kaplanova J, Vrettou E, Karina M, Kosmidis P, Fountzilas G.
    Anticancer Res; 2007 Jul 01; 27(6C):4481-9. PubMed ID: 18214064
    [Abstract] [Full Text] [Related]

  • 26. Stage IB nonsmall cell lung cancers: are they all the same?
    Jones DR, Daniel TM, Denlinger CE, Rundall BK, Smolkin ME, Wick MR.
    Ann Thorac Surg; 2006 Jun 01; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
    [Abstract] [Full Text] [Related]

  • 27. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.
    Cheng TL, Chang MY, Huang SY, Sheu CC, Kao EL, Cheng YJ, Chong IW.
    Chest; 2005 Sep 01; 128(3):1453-60. PubMed ID: 16162743
    [Abstract] [Full Text] [Related]

  • 28. Isolation of a novel human lung-specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer.
    Iwao K, Watanabe T, Fujiwara Y, Takami K, Kodama K, Higashiyama M, Yokouchi H, Ozaki K, Monden M, Tanigami A.
    Int J Cancer; 2001 Feb 15; 91(4):433-7. PubMed ID: 11251963
    [Abstract] [Full Text] [Related]

  • 29. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T, Koike T, Yoshiya K, Tsuchida M, Toyabe S.
    J Thorac Cardiovasc Surg; 2013 Aug 15; 146(2):372-8. PubMed ID: 23870323
    [Abstract] [Full Text] [Related]

  • 30. Glutathione S-transferase PI (GST-PI) mRNA expression and DNA methylation is involved in the pathogenesis and prognosis of NSCLC.
    Grimminger PP, Maus MK, Schneider PM, Metzger R, Hölscher AH, Sugita H, Danenberg PV, Alakus H, Brabender J.
    Lung Cancer; 2012 Oct 15; 78(1):87-91. PubMed ID: 22884253
    [Abstract] [Full Text] [Related]

  • 31. Detection of CK19, LUNX, and KS1/4 mRNA expression in the peripheral blood for diagnosis of micrometastases in patients with non-small cell lung cancer and their clinical implications.
    Yan L, Yao Y, Wang LH, Wang ML, Fu XH.
    Genet Mol Res; 2015 Nov 25; 14(4):15090-5. PubMed ID: 26634471
    [Abstract] [Full Text] [Related]

  • 32. Superiority and clinical significance of Lunx mRNA in the diagnosis of malignant pleural effusion caused by pulmonary carcinoma.
    Tang Y, Xu L.
    J Exp Clin Cancer Res; 2013 Jun 08; 32(1):37. PubMed ID: 23759037
    [Abstract] [Full Text] [Related]

  • 33. [Prognostic significance of ERCC1 mRNA expression in patients with non-small cell lung cancer receiving platinum-based chemotherapy].
    Qian XP, Liu BR, Shi MQ, Liu XZ, Hu WJ, Zou ZY, Wei J.
    Zhonghua Zhong Liu Za Zhi; 2009 Jan 08; 31(1):33-7. PubMed ID: 19538866
    [Abstract] [Full Text] [Related]

  • 34. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S, Kwok Y, Krasna M, Bangalore M, Suntharalingam M.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1438-43. PubMed ID: 16029805
    [Abstract] [Full Text] [Related]

  • 35. XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression.
    Bartolucci R, Wei J, Sanchez JJ, Perez-Roca L, Chaib I, Puma F, Farabi R, Mendez P, Roila F, Okamoto T, Taron M, Rosell R.
    Clin Lung Cancer; 2009 Jan 01; 10(1):47-52. PubMed ID: 19289372
    [Abstract] [Full Text] [Related]

  • 36. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G.
    Cancer; 2005 Apr 15; 103(8):1676-84. PubMed ID: 15754326
    [Abstract] [Full Text] [Related]

  • 37. [Impact of different mediastinal lymphadenectomy on clinical-stage IA non-small cell lung cancer].
    Ma K, Wang TY, He BL, Chang D, Gong M.
    Zhonghua Wai Ke Za Zhi; 2008 May 01; 46(9):670-3. PubMed ID: 18956719
    [Abstract] [Full Text] [Related]

  • 38. A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: implications for adjuvant therapy.
    Varlotto JM, Flickinger JC, Recht A, Nikolov MC, DeCamp MM.
    Cancer; 2008 Apr 01; 112(7):1547-54. PubMed ID: 18260087
    [Abstract] [Full Text] [Related]

  • 39. Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival.
    Kim SH, Choi HY, Lee J, Son DS, Lee HS, Song IS, Lim YS, Hong YS, Kim J, Choi YS.
    J Surg Oncol; 2007 Mar 15; 95(4):337-46. PubMed ID: 17326127
    [Abstract] [Full Text] [Related]

  • 40. Sentinel lymph node mapping and molecular staging in nonsmall cell lung carcinoma.
    Pulte D, Li E, Crawford BK, Newman E, Alexander A, Mustalish DC, Jacobson DR.
    Cancer; 2005 Oct 01; 104(7):1453-61. PubMed ID: 16130135
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.